CIDRAP newsletters options
The lack of awareness "likely had a role in rapid transmission," the authors note.
Also, a review of clinical guidelines on monkeypox finds a dearth of good information.
After COVID-19 issues, the CDC has a plan to prioritize public health and outbreak response.
Using a test-to-stay (TTS) strategy in K-12 schools during the winter of 2021-22 resulted in substantial reduction in missed school days, according to a study yesterday in Pediatrics.
Prescribing data from a children's hospital network in Chicago showed considerable variation in antibiotic durations for children treated for community-acquired pneumonia (CAP) and urinary tract infections (UTIs) in ambulatory settings, with the variability largely unrelated to the severity of symptoms, researchers reported late last week in the Journal of the Pediatric Infectious Diseases Society.
Hospitalized adult COVID-19 patients before and after SARS-CoV-2 vaccine availability had significantly higher odds of venous—but not arterial—thromboembolism than those hospitalized for influenza before the pandemic, finds a study published today in JAMA.
New data suggest that vaccination of only known contacts may not by itself prevent transmission.
Becton, Dickinson and Company (BD) and Accelerate Diagnostics yesterday announced a commercial collaboration agreement to bring rapid identification and antibiotic susceptibility tests to more clinicians and patients worldwide.
A study of more than 2,900 healthcare workers (HCWs) shows that those who wore a respirator were more than 40% less likely to be infected with COVID-19 than those wearing a surgical mask.
Rates of severe pregnancy-related complications and severe maternal illness and death rose significantly.
The process generates a list of antibiotics to which the infection is susceptible.
Also, 4 studies shed light on symptoms, diagnosis, and spread, with 1 paper detailing asymptomatic cases.
A clinician-directed intervention implemented at facilities in the Veterans' Healthcare Administration (VHA) was associated with better management of, and reduced antibiotic prescribing for, acute respiratory infections (ARIs), researchers reported today in Infection Control & Hospital Epidemiology.
Following the Food and Drug Administration (FDA) emergency use authorization (EUA) of the Novavax COVID-19 vaccine last month for the primary vaccine series, the company announced today that it has applied for an EUA for the vaccine to also be used as a booster in adults ages 18 and older.
About 27% of kids hospitalized for COVID-19 or MIS-C had symptoms 2 to 4 months later.
Only 86% of New York City preschoolers have received the recommended 3 doses of polio vaccine.
COVID-19 patients early in the pandemic had 4% higher healthcare use in the 6 months after illness onset than matched controls, most notably for infection-related conditions, hair loss, bronchitis, pulmonary embolism or deep vein thrombosis, and shortness of breath, finds a study today in JAMA Network Open.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Maine, which has confirmed only four monkeypox cases, today reported a case of the virus in a resident under the age of 18. No further details were released by the Maine Centers for Disease Control. Maine now joins California and Florida as states with pediatric cases.
Also, researchers in Spain detail a possible human-to-dog case.
In kids, lingering symptoms often occurred after mild illness and were more common in unvaccinated youngsters.
